Acclarent Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 240

Employees

  • Latest Deal Type
  • M&A

  • Latest Deal Amount
  • $280M

Acclarent General Information

Description

Developer of medical devices intended to address conditions affecting the ear, nose, and throat. The company primarily focuses on commercializing balloon sinuplasty devices, which are minimally invasive tools that aid physicians in treating patients suffering from chronic sinusitis, enabling doctors to navigate the sinus anatomy and open blocked sinus ostia and passageways to allow for sinus drainage.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 33 Technology Drive
  • Irvine, CA 92618
  • United States
Primary Industry
Surgical Devices
Other Industries
Medical Supplies
Corporate Office
  • 33 Technology Drive
  • Irvine, CA 92618
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Acclarent Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Merger/Acquisition 01-Apr-2024 $280M Completed Generating Revenue
6. Merger/Acquisition 20-Jan-2010 Completed Generating Revenue
5. IPO 06-Jun-2008 Cancelled Generating Revenue
4. Later Stage VC (Series D) 31-Mar-2008 Completed Generating Revenue
3. Later Stage VC (Series C) 23-Apr-2007 Completed Generating Revenue
2. Early Stage VC (Series B) 27-Dec-2005 $28M $42.6M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2003 $14.5M $14.5M Completed Generating Revenue
To view Acclarent’s complete valuation and funding history, request access »

Acclarent Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series D
Series C
Series B 13,357,773 $0.17 $2.1 $2.1 1x $2.1 22.7%
Series A 14,071,484 $0.08 $1.04 $1.04 1x $1.04 23.78%
To view Acclarent’s complete cap table history, request access »

Acclarent Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of medical devices intended to address conditions affecting the ear, nose, and throat. The company primarily f
Surgical Devices
Irvine, CA
240 As of 2008

Miami, FL
 

Shelton, CT
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acclarent Competitors (12)

One of Acclarent’s 12 competitors is Dalent, a Venture Capital-Backed company based in Miami, FL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dalent Venture Capital-Backed Miami, FL
Spine Wave Venture Capital-Backed Shelton, CT
DePuy Spine Corporation Raynham, MA
Navigate Surgical Technologies Venture Capital-Backed Vancouver, Canada
NEUROMARK Venture Capital-Backed Braintree, MA
You’re viewing 5 of 12 competitors. Get the full list »

Acclarent Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acclarent Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Delphi Ventures (California) Venture Capital Minority
Ethicon Corporation Majority
ExploraMed Accelerator/Incubator Minority
Johnson & Johnson JJDC Corporate Venture Capital Minority
Meritech Capital Partners Venture Capital Minority
You’re viewing 5 of 7 investors. Get the full list »

Acclarent FAQs

  • When was Acclarent founded?

    Acclarent was founded in 2003.

  • Where is Acclarent headquartered?

    Acclarent is headquartered in Irvine, CA.

  • What is the size of Acclarent?

    Acclarent has 240 total employees.

  • What industry is Acclarent in?

    Acclarent’s primary industry is Surgical Devices.

  • Is Acclarent a private or public company?

    Acclarent is a Private company.

  • What is the current valuation of Acclarent?

    The current valuation of Acclarent is .

  • What is Acclarent’s current revenue?

    The current revenue for Acclarent is .

  • How much funding has Acclarent raised over time?

    Acclarent has raised $104M.

  • Who are Acclarent’s investors?

    Delphi Ventures (California), Ethicon, ExploraMed, Johnson & Johnson JJDC, and Meritech Capital Partners are 5 of 7 investors who have invested in Acclarent.

  • Who are Acclarent’s competitors?

    Dalent, Spine Wave, DePuy Spine, Navigate Surgical Technologies, and NEUROMARK are some of the 12 competitors of Acclarent.

  • When was Acclarent acquired?

    Acclarent was acquired on 01-Apr-2024.

  • Who acquired Acclarent?

    Acclarent was acquired by Integra LifeSciences Holdings.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process